Asia Vital Components (Taiwan), TW0003017000

Asia Vital Components (Taiwan) stock fell 2.96 percent amid probe

Published on 10/08/2026 at 09:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Asia Vital Components (Taiwan) stock fell 2.96 percent on October 8 after a factory investigation was disclosed. Q2 revenue rose 66 percent year over year.

Asia Vital Components (Taiwan), TW0003017000, Illustration mit AI erstellt.
Asia Vital Components (Taiwan), TW0003017000, Illustration mit AI erstellt.

Asia Vital Components (Taiwan) stock (ISIN TW0003017000) was last at TWD 3,440 on the Taiwan Stock Exchange on October 8, 2026 at 1:30 p.m. TST, down 2.96 percent from TWD 3,545. The move followed a company disclosure that investigators had searched a Xinzhung facility in connection with a subsidiary's 2023 listing application, while the company said the matter had no operational or financial impact, according to Cnyes on October 7, 2026.

Investigation creates a new risk marker

The disclosure concerns specific employees and the listing process of subsidiary Fu Shih Da in 2023, rather than a new operating warning. Asia Vital Components said it would cooperate with the legal process, according to Cnyes.

For investors, the key distinction is between a disclosed investigation and a quantified business impact. The company statement cited by Cnyes assigned no impact to operations or finances, leaving the stock's October 8 decline as the immediate market signal.

Q2 growth remains the earnings anchor

Asia Vital Components generated TWD 49.1 billion in Q2 2026 revenue, a 66 percent year-over-year increase, while gross margin reached 32.57 percent, according to Investify. The same source reported that quarterly net profit was nearly 2.4 times the year-earlier level, placing the investigation against a period of rapid operating expansion.

The company is also committing capital to Vietnam. A civil construction and mechanical-electrical contract for the next phase of its Ninh Binh project totaled TWD 7.781 billion, while the company planned TWD 15 billion of 2026 capital expenditure, according to Investify. The contract therefore equaled more than half of the stated annual capex plan, although construction spending can be distributed across multiple periods.

Consensus target stays above the quote

ToAlpha showed a Buy consensus from 18 analysts on October 7, 2026, with a median target of TWD 3,894, a high of TWD 4,500 and a low of TWD 2,150, according to ToAlpha. Against the October 8 price of TWD 3,440, the median target lies 13.2 percent above the quote, keeping earnings delivery and legal clarity as the two most visible valuation checkpoints.

Asia Vital Components stock remains near its yearly high

The stock's October 8 range was TWD 3,410 to TWD 3,515, while its 52-week range was TWD 1,085 to TWD 3,700. Market capitalization stood at TWD 1.4 trillion and volume reached 3,155,899 shares on the same date.

Asia Vital Components (Taiwan) stock facts

  • Company: Asia Vital Components Co., Ltd.
  • ISIN: TW0003017000
  • Ticker: 3017.TW
  • Trading venue: Taiwan Stock Exchange
  • Price (as of October 8, 2026, 1:30 p.m. TST): TWD 3,440
  • Market capitalization: TWD 1.4 trillion (as of October 8, 2026)
  • 52-week range: TWD 1,085-3,700 (as of October 8, 2026)
  • Sector / Industry: Information Technology / Computer Hardware

Upcoming dates for Asia Vital Components (Taiwan) stock

  • November 11, 2026: Q3 2026 earnings date, according to InvestPane

More news and analyses on Asia Vital Components stock

Disclaimer...

en | TW0003017000 | ASIA VITAL COMPONENTS (TAIWAN) | boerse | 70263376 | bgmi